The concept of prothrombin as the specific precursor of thrombin dates from the so-called classical theory of blood coagulation put forward by Schmidt (1895) and Morawitz (1905) . This theory, which considers that four factors, thromboplastin, prothrombin, calcium, and fibrinogen, are concerned in the formation of fibrin, has been the basis of most modern work. The theory was of more academic than practical importance until the discovery of vitamin K and the use of dicoumarin in treatment of thrombosis, both of which required the quantitative estimation of prothrombin. The available methods are all based on the assumption that the classical theory is fundamentally sound.
Of the methods of prothrombin estimation that have been developed, none can measure prothrombin directly and therefore infer its concentration from observations on thrombin. The one-stage technique of Quick (1942) has been the most commonly used because it is simple, easily performed, requires little in the way of special reagents, and gives results which are in general agreement with clinical experience. The method consists of adding an optimum amount of brain thromboplastin and calcium to oxalated plasma, under which conditions the clotting time of the mixture is assumed to be proportional to its prothrombin concentration. The basis of this supposed relationship is the literal acceptance of the classical theory. If three of the four variables are controlled, then variations in the fourth must determine any alteration in the rate of fibrin production, which is in turn indicated by a change in the clotting time of the mixture. In practice thromboplastin and calcium are controlled, if possible at or near their optimum concentrations, and fibrinogen variations found in the ordinary clinical material are usually not of sufficient magnitude to influence the result. The remaining variable is therefore prothrombin.
The method is essentially dynamic in principle, depending entirely on the rate of thrombin generation and not on the amount of thrombin that may finally be produced. It depends also on the assumption that there are no uncontrolled factors other than prothrombin that might modify this rate of thrombin generation. It is now known, of course, that this is not the case. Not only may the reaction time of fibrinogen vary, but accelerators and depressors of thrombin generation are present in normal plasma, and variation in these accelerators and depressors in pathological conditions may alter the results of this test. Quick (1942) himself has been the first to recognize this. The practical implications of the fallacious nature of this method are difficult to assess at present, but no alternative to it is available for routine use. Though theoretically the two-stage method appears to be on much firmer ground, since it seeks to estimate the total amount of thrombin generated, it is too complex for ordinary routine use. There are, moreover, many indications that its results may be equally fallacious.
In dicoumarin therapy one component of prothrombin (prothrombin B of Quick, 1947 ) is deliberately lowered, and the responsibility for a reduction to haemorrhagic levels rests largely with the pathologist. A reliable method of prothrombin determination is therefore essential. There has recently been much discussion as to which of the modifications of the one-stage technique give the best results (Marsh, 1947 (Marsh, , 1948 James, 1948; Cleland, 1947; Pivawar, 1947; Lempert, 1948; Canti and Robertson, 1948 (Bingham and others, 1941; Butsch and Stewart, 1942; Meyer and others, 1942; Shapiro and others, 1943; Barker and others, 1945; Bingham and others, 1943; Gefter and others, 1944; Barker and others, 1943 ; Jaques and Dunlop, 1945a; Quick, 1945; Cotlove and Vorzimer, 1946; Allen, 1947; Glueck and others, 1948; etc.) (Fullerton, 1940; Page and Russell, 1941 ;  Page and others, 1941-2a and b; Page and de Beer, 1942-3; Page and de Beer, 1943 ; Shapiro, Sherwin, Redish, and Campbell, 1942) or Russell's viper venom and lecithin (Witts and Hobson, 1940 and Hobson and Witts, 1941) . It has been recognized for many years that certain snake venoms are powerful coagulants, and Martin (1894) was one of the first to investigate their action. Some, such as the venom of Echis carinatus and Notechis scutatus, are thrombin-like in nature as they clot oxalated blood. Lamb (1903) observed that Russell's viper venom was almost devoid of this thrombin-like effect, and the immensely powerful thromboplastin-like action of the venom was largely overlooked until Macfarlane and Barnett (1934) (1936) found that the action of the venom was greatly potentiated by tissue extracts and by use of lecithin. Macfarlane (1938) observed that plasma deprived of platelets by high-speed centrifuging was only slowly clotted by venom, while Macfarlane and others (1941) -Venous blood is collected in a dry syringe and added to 2 per cent potassium oxalate solution in the proportion of nine parts of blood to one part of oxalate. The mixture is inverted several times and the plasma removed after centrifuging at 1,500 r.p.m. for 15 minutes. The plasma should be kept in the refrigerator and used within 6 hours of collection because the coagulation time of pathological plasmas may alter rapidly on storage.
2. Preparation of thromboplastin.-Fresh human brain is collected from the post-mortem room, all superficial vessels and meninges are removed, and the substance is macerated with acetone in a mortar. The acetone is. rep aced several times and the granular powder dried on a suction filter. When completely free from acetone the powder is kept in bottles at room temperature. This material can be stored for three months without deterioration.
3. Preparation of thromboplastin for use.-0.5 g. of the dried powder are suspended in 5 ml. of 0.85 per cent saline and the mixture is incubated at 37' C. fQr 15 minutes. The suspension is centrifuged for 5 nminutes at 1,500 r.p.m. and the supernatant emulsion is diluted 1 in 10 with 0.85 per cent saline. The solution should be made up freshly as required, and this concentration was usually found to be the optimum for levels of prothrombin between 5 and 100 per cent (see below).
4. Calcium chloride solution.-2.875 g. of anhydrous calcium chloride are dissolved in 1,000 ml. of distilled water to make a 0.025 molar solution.
5. Pcrformance of the test.-0.1 ml. of undiluted normal plasma is added to 0.1 ml. of brain enulsion and the mixture is warmed to 370 C. in a water bath. 0.1 ml. of 0.025 M calcium chloride is then added rapidly from a graduated Pasteur pipette and the coagulation time is recorded from the time of addition of the calcium. The test should be made in triplicate and the mean of three readings recorded. The same procedure is repeated with the abnormal plasma. If the normal p'asma gives a clotting time of more than 30 seconds the technique is unsatisfactory.
6. The optimum concentration of brain thromboplastin and calcium (a) Brain thromboplastin.-Aggel.r and Lucia (1938) have shown that prolongation of the coagulation time occurred with both high and low concentrations of brain emulsion. With normal undiluted plasma the range within which a minimum coagulation time occurred was wide, but with pathological or diluted plasmas the optimum range was limited. Similar results were obtained in this laboratory. The optimum concentration usually corresponded to the dilution mentioned 35 group.bmj.com on November 7, 2017 -Published by http://jcp.bmj.com/ Downloaded from above, but different batches of brain vary slightly. The optimum concentration may be-determined as follows: 0.5 g. of dried brain are suspended in 5 ml. of saline and the supernatant emulsion removed as described above. This concentration is called 100 per cent, and from this a number of dilutions are made. Plasma containing various amounts of prothrombin is then prepared by dilution with saline or protlirombin-free plasma. In one experiment the curves shown in Fig. 1 were obtained.
(b) Calcium- Jaques and Dunlop (1945b) have shown that the use of an optimum concentration of calcium is important. As with brain thromboplastin the optimum concentration is much more limited with low levels of prothrombin. It was found to be 0.1 ml. of a 0.025 M solution as used in Quick's test.
7. The expression of results.-If the clotting time of plasma is related to its prothrombin concentration the clotting time of an abnormal plasma must be compared to that of a normal before any inference can be drawn as to its relative prothrombin content. Many authors have made this comparison by dividing the clotting time of the normal plasma by that of the abnormal and expressing the result as a percentage. The " prothrombin index" thus obtained is based on the assumptionthat the concentration of prothrombin bears a linear relation to the clotting time, whereas in fact the two variables are related by a hyperbolic curve. of the concentration of prothrombin (Fig. 4) .
Example.-Coagulation time of normal plasma: 18 seconds. Coagulation time of abnormal plasma: 42 seconds. Curve C in Fig. 4 (Fig. 3) group.bmj.com on November 7, 2017 -Published by http://jcp.bmj.com/ Downloaded from 3ROSfJAjRY BIGGS, A-ND R. G.--MACFARLANE ordinate through 42 seconds it will be seen that this Concentratib of crosses the selected curve at a level of prothrombin Prothrombln % equivalent to a dilution of 10 per cent in the normal plasma; the plasma would therefore be said to con-00 tain 10 per cent of prothrombin.
This method of standardization is clearly quite 90 arbitrary, and while the results with any one set of calibration curves will be comparable, the results from different hospitals can be related only if the reference curves are given. In much of the published work this ,has not been done.
(b) WrIrS AND HoBSON's TECHNIQUE
The technique is essentially similar to that of Quick except that brain thromboplastin is replaced by a 1 in 10,000 solution of Russell's viper venom (Burroughs Wellcome's "Stypven ") to 1 ml., of which 0.1 ml. of a 1 per cent alcoholic solution of crude lecithin is added. The saline dilution curves in normal plasmas are remarkably constant, and in most cases one curve will suffice for the expression of results as percentage of prothrombin. However, as with brain thromboplastin, different diluents give different curves (Fig. 5) the ninth day, when there was a fall to 25 per cent and a low level was maintained for four days (Fig. 6 ).
Case 2.-Mrs. C. D., aged 44, was treated with dicoumarin for thrombophlebitis of the leg with pulmonary embolus following a hysterectomy for fibroid. 1,100 mg. of dicoumarin were given in the first eleven days and a significant fall of prothrombin was delayed until the tenth day, when readings of 14, 30, and 15 per cent were recorded on three consecutive days (Fig. 7) . Case 3.-Mrs. E. C., aged 53, was given dicoumarin following operation for prolapse to prevent the occurrence of femoral thrombosis. She was given 700 mg. dicoumarin in the first four days, and on the fifth day had severe haemorrhage from the operation site which necessitated transfusion of 2 pints of blood. The surgeons could find no local cause for this bleeding. Her prothrombin time remained within normal limits throughout.
These cases followed a course similar to that described by Wright and Prandoni (1942) , who used Russell's viper venom for prothrombin estimation. Large doses of dicoumarin were necessary to prolong the prothrombin time, the fall of -prothrombin was delayed, and unpredictable haemorrhage occurred. There was a marked lack of correspondence between the results of the two methods (Fig. 8) .
These cases suggest that Witts and Hobson's technique is far less sensitive than that of -Quick in recording the hypoprothrombinaemia of dicoumarin therapy. In order to substantiate this probability the course of the prothrombin was followed by both techniques simultaneously in the next three cases.
Case 6.-Mr. H., aged 71, was treated with dicoumarin for thrombophlebitis following a cystotomy for benign prostatic hypertrophy. He was given 500 mg. of dicoumarin in the first two days. By Quick's technique the prothrombin dropped suddenly to 9 per cent on the third day and fell to 5 per cent on the fifth day, when there was a slight urinary haemorrhage. He was given vitamin K, the haemorrhage ceased rapidly, and the prothrombin returned to normal in four days. By Witts and Hobson's technique the prothrombin was significantly abnormal on two days only, and at the time of haemorrhage a level of 35 per cent was recorded (Fig. 9) .
Case 7.-Mrs. F., aged 73, was treated with dicounarin for thrombophlebitis of the leg following operation of the left obturator nerve. She was given 800 mg. during the first thirteen days, and the relative sensitivity of Witts and Hobson's and Quick's techniques is shown in Fig. 10 group.bmj.com on November 7, 2017 -Published by http://jcp.bmj.com/ Downloaded from Case 8.-Mr. D., aged 45, was given dicoumarin for treatment of pulmonary thrombosis following appendicectomy. 500 mg. were given in the first three days, and the patient showed an unusually marked response to the drug when the prothrombin was estimated with a brain thromboplastin (Fig. 11) This hypothesis can be tested if normal plasma is diluted with naturally occurring prothrombindeficient plasma in which it is assumed that only prothrombin is reduced. Curves constructed from the coagulation times of various mixtures of normal plasma with prothrombin-deficient plasmas are shown in Figs. 12 and 13. Fig. 12 was derived from a vitamin-K deficient plasma which showed only a trace of prothrombin, and in Fig. 13 plasma give much shorter coagulation times than are recorded by corresponding mixtures with saline or artificial prothrombin-free plasma. Moreover, the alteration in clotting time between 100 and 10 per cent becomes immeasurably small, giving a total range of clotting times from 7 to 11 seconds. With brain thromboplastin the discrepancy is much less marked. The next problem that arises is which -of the plasma constituents other than prothrombin is responsible for th'e discrepancy. One factor which is easily tested is the presence of platelets. It will be seen from Fig. 14 that when Russell's viper venom and lecithin thromboplastin is used the addition of .platelets to mixtures of' normal and prothrombin-free p1 a s m a causes a reduction in the coagulation time which is particularly marked at low levels of prothrombin.
In fact this thromboplastin appears to measure a reduction in platelets as much as the fall in prothrombin concentration.
The extraordinary lack of sensitivity of Russell's viper venom and lecithin thromboplastin to changes in prothrombin concentration probably lies in the mechanism of thrombin generation. From the reaction of normal plasma to thrombin it can be calculated that only 5 per cent of the available thrombin that could be formed by a normal plasma is necessary for its coagulation, and it is the speed with which this level of thrombin is reached that controls the one-stage coagulation time. In Fig. 15 the early stages of thrombin generation haver been followed in a normal plasma and in the plasma of a patient under treatment with dicoumarin. The minimum le*el of thrombin for rapid coagulation of the plasma has been indicated. If the discrepancy between Russell's viper venom and lecithin and brain thromboplastin results from a differential sensitivity to factors other than prothrombin, a similar difference should occur in all types of hypoprothrombinaemia. In a limited series of pathological cases such a discrepancy was found (Table II) . a relative measure of the speed of production of the small amount of thrombin necessary for coagulation. It might save confusion if all pretence at measuring " prothrombin percentage " were abandoned and the results were expressed as " relative prothrombin efficiency" or, as was suggested by Witts (1942) and Witts and Hobson (1942) , an " accelerated clotting time " in percentage of normal.
The value of the test depends essentially on its ability to predict a haemorrhagic level. Bollman and Preston (1942) have shown that haemorrhage following dicoumarin administration is not directly proportional to the " concentration of prothrombin." In the patients described here it is clear that Cases 3 and 6 had a particular predisposition to the haemorrhage. Fortunately haemorrhage often fails to occur with a very low content of prothrombin, and Barker and others (1945) 
